Emergent BioSolutions to Participate in Investor Conferences
January 03 2022 - 6:30AM
Emergent BioSolutions Inc. (NYSE: EBS) announced today that members
of the company’s executive management team will participate in the
following investor conferences in the first quarter of 2022:
- 40th Annual J.P. Morgan Healthcare
Conference January 10 to 13, 2022Company presentation
scheduled on January 10 at 8:15 am PSTClick for
Webcast
- J.P. Morgan 2022 Global High Yield & Leveraged
Finance ConferenceFebruary 28 to March 2, 2022Company
presentation scheduled on February 28 at 2:00 pm EST
- Cowen & Co. 42nd Annual Health Care
ConferenceMarch 7 to 9, 2022Presentation date and time
will be updated on the Emergent website as the information becomes
available
For conferences where a presentation is planned, the company’s
webcast presentation may include a discussion of the company's
recent business developments as well as its financial results and
guidance. The webcasts will be available both live, if possible,
and by replay, and will be accessible from the Emergent
website.
About Emergent BioSolutionsEmergent
BioSolutions is a global life sciences company whose mission is to
protect and enhance life. Through our specialty products and
contract development and manufacturing services, we are dedicated
to providing solutions that address public health threats. Through
social responsibility, we aim to build healthier and safer
communities. We aspire to deliver peace of mind to our patients and
customers so they can focus on what’s most important in their
lives. In working together, we envision protecting or enhancing 1
billion lives by 2030. For more information, visit our website and
follow us on LinkedIn, Twitter, and Instagram.
Investor Contact:Robert G.
BurrowsVice President, Investor
Relations240-631-3280burrowsr@ebsi.com
Media Contact:Matt HartwigSenior
Director, Media Relationsmediarelations@ebsi.com
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Emergent Biosolutions (NYSE:EBS)
Historical Stock Chart
From Apr 2023 to Apr 2024